Return of the cycad hypothesis - Does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?

Neuropathology and Applied Neurobiology

Volumn 31, Issue 4, 2005, Pages 345-353

  Ince, Paul G ^a,c   Codd, G A ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

ALS; ALS PDC; BMAA; Cyanobacteria; Cycad; Guam; Pathology

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; ALKALOID; AMINO ACID; ANATOXIN A; BACTERIAL TOXIN; CHOLINESTERASE INHIBITOR; CYANOGINOSIN; CYANOTOXIN; NEUROMUSCULAR BLOCKING AGENT; NEUROTOXIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CYANOBACTERIUM; DEMENTIA; DIETARY INTAKE; ETHNOBOTANY; GUAM; HUMAN; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA; TOXIN ANALYSIS;

AMYOTROPHIC LATERAL SCLEROSIS; BACTERIAL TOXINS; BRAIN; CYANOBACTERIA; CYCAS; GUAM; HUMANS; MARINE TOXINS; MICROCYSTINS; NEUROFIBRILLARY TANGLES; PARKINSONIAN DISORDERS; PLANT ROOTS; PLANTS, EDIBLE;

EID: 23044505197     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2005.00686.x     Document Type: Review

References (57)

1. Sacks O. Cycad island. In The Island of the Colorblind. New York: Vintage, 1998; 97-177
2. Spencer P, Palmer V, Herman A, Asmedi A. Cycad use and motor neurone disease in Man Jaya. Lancet 1987; 2: 1273-4
3. Mulder D, Kurland L, Iriate L. Neurologic diseases on the island of Guam. US Armed Forces Med J 1954; 5: 1724-39
4. Spencer P, Nunn P, Hugon J, Ludolph A, Roy D. Motor-neurone disease on Guam: possible role of a food neurotoxin. Lancet 1986; 1: 965
5. Vega A, Bell A. α-Amino-β-methylaminopropionic acid, a new amino acid from the seeds of Cycas circinalis. Phytochemistry 1967; 6: 759-62
6. Vega A, Bell A, Nunn P. The preparation of L- and D α-amino-β- methylaminopropionic acid and the identification of the compound isolated from Cycas circinalis as the 1-isomer. Photochemistry 1968; 7: 1885-7
7. Spencer PS, Nunn PB, Hugon J. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987; 237: 517-22
8. Duncan W, Steele J, Kopin I, Stanford P. 2-Amino-3-(methylamino) -propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 1990; 40: 767-72
9. Spencer P, Kisby G, Ludolph A. Slow toxins, biological markers, and long latency neurodegenerative disease in the western Pacific region. Neurology 1991; 41 (Suppl.): 62-6
10. Banack S, Cox P. Distribution of the neurotoxic nonprotein amino acid BMAA in Cycas micronesia. Bot J Linn Soc 2003; 143: 165-8
11. Banack S, Cox P. Biomagnification of cycad neurotoxins in flying foxes. Neurology 2002; 61: 387-9
12. Cox P, Sacks O. Cycad neurotoxins, consumption of flying foxes and ALS/PDC disease in Guam. Neurology 2002; 58: 956-9
13. Monson C, Banack S, Cox P. Conservation implications of Chamorro consumption of flying foxes as a possible cause of amyotrophic lateral sclerosis-parkinsonism dementia complex in Guam. Conserv Biol 2003; 17: 678-86
14. Murch S, Cox P, Banack S. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci USA 2004; 101: 12228-31
15. Esclaire F, Kisby G, Spencer P, Milne J, Lesort M, Hugon J. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Exp Neurol 1999; 155: 11-21
16. Hoffmann G, Crowley D, Theophiles P. Comparative potencies of induction of point mutations and genetic duplications by the methylating agents methylazoxymethanol and dimethyl sulfate in bacteria. Mutagenesis 2002; 17: 439-44
17. Kisby G, Spencer P. Neurotoxic amino acids from the cycad carcinogen methylazoxymethanol. In ALS New Advances in Toxicology and Epidemiology. Eds F Rose, F Norris. London: Smith-Gordon, 1990; 35-9
18. Cox P, Banack S, Murch S. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci USA 2004; 100: 13380-3
19. Codd G, Morrison L, Metcalf J. Cyanobacterial toxins: risk management for health protection. Toxicol Appl Pharmacol 2005; 203: 264-72
20. Codd G, Bell S, Kaya K, Ward C, Beattie K, Metcalf J. Cyanobacteria toxins, exposure routes and human health. Eur J Phycol 1999; 34: 405-15
21. Codd G, Bell S. Occurrence, Fate and Behaviour of Cyanobacterial (Blue-Green Algal) Hepatotoxins. Marlow, England: National Rivers Authority, 1995. Foundation for Water Research. Report No.: R&D Project Record 271/77A
22. Perl T, Bedard L, Kosatsky T, Hockin J, Todd E, Remis R. An outbreak of toxic encephalopathy caused by mussels contaminated with domoic acid. N Engl J Med 1990; 322: 1775-80
23. Murch S, Cox P, Banack S, Steele J, Sacks O. Occurence of β-methylamino-L-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand 2004; 110: 267-9
24. Hirano A, Arumugasamy N, Zimmerman H. Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch Neurol 1967; 16: 357-63
25. Hirano ANM, Elizan T, Kurland L. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam: further pathologic studies. Arch Neurol 1966; 15: 35-51
26. Hirano A, Kurland L, Krooth R, Lessell S. Parkinsonism-dementia complex, an endemic disease on the ilsand of Guam. I. Clinical Features. Brain 1961; 84: 642-61
27. Hirano A, Malamud N, Kurland L. Parkinsonism-dementia complex, and endemic disease on the island of Guam. II. Pathological features. Brain 1961; 84: 662-79
28. Malamud N, Hirano A, Kurland L. Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Neurology 1961; 5: 401-14
29. Hof P, Perl D. Neuroflbrillary tangles in the primary motor cortex in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex. Neurosci Lett 2002; 328: 294-8
30. Buee-Scherrer V, Buee L, Hof P, Leveugle B, Gilles C, Loerzel A, Perl D, Delacourte A. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: immunocytochemical profile of tau proteins. Am J Pathol 1995: 924-32
31. Schmidt M, Zhukareva V, Perl D, Sheridan S, Schick T, Lee V-Y, Trojanowski J. Spinal cord neurofibrillary pathology an Alzheimer disease and Guam parkinsonism-dementia complex. J Neuropathol Exp Neurol 2001; 60: 1075-86
32. Ince P, Morris C, Perry E. Dementia with Lewy bodies: a distinct non-Alzheimer dementia? Brain Pathol 1998; 8: 299-324
33. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998; 24: 104-17
34. Matsumoto S, Hirano A, Goto S. Spinal cord neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia complex: an immunohistochemical study. Neurology 1990; 40: 975-9
35. Leigh P, Dodson A, Swash M, Brion J-P, Anderton B. Cytoskeletal abnormalities in motor neuron disease: an immunocytochemical study. Brain 1989; 112: 521-35
36. Leigh PN, Anderton BH, Dodson A, Gallo J-M, Swash M, Power D. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett 1988; 93: 197-203
37. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin J, Gallo J, Weller R, Anderton B. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: morphology, distribution and specificity. Brain 1991; 114: 775-88
38. Lowe J, Aldridge F, Lennox GFD, Jefferson D, Landon M, Mayer R. Inclusion bodies in motor cortex and brainstem of patients with motor neuron disease are detected by immunocytochemical localisation of ubiquitin. Neurosci Lett 1989; 105: 7-13
39. Murayama S, Ookawa Y, Mori H, Nakano I, Ihara Y, Kuzahara S, Tomonaga M. Immunocytochemical and ultrastructural study of Lewy body-like inclusions in familial amyotrophic lateral sclerosis. Acta Neuropathol 1989; 78: 143-52
40. Okamoto K, Hirai S, Yamazaki Y, Sun X, Nakazoto Y. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 1991; 129: 233-6
41. Matsumoto S, Hirano A, Goto S. Ubiquitin-immunoreactive filamentous inclusions in the anterior horn cells of Guamanian and non-Guamanian amyotrophic lateral sclerosis. Acta Neuropathol 1990; 80: 23-8
42. Morris H, Al-Sarraj A, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood N, Hardy J, Lees A, McGeer P, Daniel S, Steele J. A clinical and pathological study of motor neurone disease on Guam. Brain 2001; 124: 2215-22
43. Oyanagi K, Makifuchi T, Ohtoh T, Chen K, van der Schaaf T, Gajdusek D. Amyotrophic lateral sclerosis of Guam: the nature of the neuropathological findings. Acta Neuropathol 1994; 88: 405-12
44. Konagaya M, Kato T, Sakai M, Kuru S, Matsuoka Y, Konagaya T, Hashizume Y, Tabira T. A clinical and pathological study of a Japanese case of amyotrophic lateral sclerosis/parkinsonism-dementia complex with family history. J Neurol 2003; 250: 164-70
45. Perl D, Hof P, Purohit D, Loerzel A, Kakulas B. Hippocampal and entorhinal cortex neurofibrillary tangle formation in Guamanian Chamorros free of overt neurologic disease. J Neuropathol Exp Neurol 2003; 62: 381-8
46. Wightman G. Anderson V, Martin J, Swash M, Anderton B, Neary D, Mann D, Luthert P, Leigh P. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 1992; 139: 269-77
47. Ikemoto A, Hirano A, Akiguchi I, Kimura J. Comparative study of ubiquitin immunoreactivity of hippocampal granular cells in amyotrophic lateral sclerosis with dementia, Guamanian amyotrophic lateral sclerosis and Guamanian parkinsonism-dementia complex. Acta Neuropathol 1997; 93: 265-70
48. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding superoxide dismutase: molecular pathology of live new cases and comparison with 73 sporadic cases and previous reports. J Neuropathol Exp Neurol 1998; 57: 895-904
49. Piao Y-S, Wakabayashi K, Kakita A, Yamada M, Hayashi S, Monta T, Ikuta F, Oyanagi K, Takahashi H. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2003; 12: 10-22
50. Bunina T. Intracellular inclusions in familial amyotrophic lateral sclerosis. Zh Nevropatol Psikhiatr 1962: 62: 1293-9
51. Wada M, Uchihara T, Nakamura A, Oyanagi K. Bunina bodies in amyotrophic lateral sclerosis on Guam: a histological, immunohistochemical and ultrastructural investigation. Acta Neuropathol 1999; 98: 150-6
52. Mikolaenko I, Pletnikova O, Kawas C, O'Brien R, Resnick S, Grain B, Troncoso J. Alpha-synuclein lesions in normal ageing, Parkinson's disease and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Ageing. J Neuropathol Exp Neurol 2005; 64: 156-62
53. Parkkinen L, Soininen H, Alafuzoff I. Regional distribution of alpha-synuclein pathology in unimpaired ageing and in Alzheimer disease. J Neuropathol Exp Neurol 2003; 62: 363-7
54. Yamazaki M, Arai Y, Baba M, Iwatsubo T, Mori O, Katayama Y, Oyanagi K. Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex. J Neuropathol Exp Neurol 2000; 59: 585-91
55. Forman M, Schmidt M, Kasturi S, Perl D, Lee V-Y, Trojanowski J. Tau and alpha-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam. Am J Pathol 2002; 160: 1725-31
56. Sebeo J, Hof P, Perl D. Occurence of α-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex. Acta Neuropathol 2004; 107:497-504
57. Oyanagi K, Tsuchiya K, Yamazaki M, Ikeda K. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features. J Neuropathol Exp Neurol 2001: 60: 393-402